Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Top Microbiol Immunol. 2011;348:89-113. doi: 10.1007/82_2010_111.

Design of small-molecule Smac mimetics as IAP antagonists.

Author information

  • 1Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. shaomeng@umich.edu

Abstract

Smac/DIABLO, discovered in 2000 as a protein released from mitochondria into the cytosol in response to apoptotic stimuli, functions as an endogenous antagonist of X-linked inhibitor of apoptosis protein (XIAP) and several other IAP proteins through direct binding. The interaction between Smac and IAPs involves the AVPI tetrapeptide binding motif on the N-terminus of Smac and a well-defined groove on the surface of these IAP proteins, providing an ideal site for the design of small-molecule Smac mimetics. Potent and cell-permeable small-molecule Smac mimetics have provided powerful pharmacological tools for study of the regulation of apoptosis by IAP proteins, and several such compounds are now in early clinical trials as new anticancer agents.

PMID:
21072626
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk